Find policies, billing codes, payers, states, and providers
HCPCS H0009: Alcohol and/or Drug Services, Acute Detoxification (Hospital Inpatient)
HCPCS Level II code H0009 denotes inpatient acute detoxification services for patients undergoing medically managed withdrawal from alcohol or other substances. This code is used to bill hospital inpatient stays focused on stabilizing patients during acute withdrawal, a critical juncture in substance use disorder care. Nationally, acute detoxification services are central to managing withdrawal risks, reducing immediate medical complications, and connecting patients to follow-up addiction treatment.
Key payers addressed in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of coverage patterns and payer inclusion, clinical context for the service, and links to related inpatient detoxification codes. The publication highlights national billing considerations, typical sites of service, and common clinical scenarios associated with acute inpatient detoxification.
This summary provides clinicians, billing professionals, and policy analysts with concise guidance on the purpose of the code, who commonly pays for the service, and what to expect in terms of clinical context and related billing avenues. Data not available in the input is clearly noted where applicable.
Customize your policy alerts
Sign up for hcpcs H0009 policy alerts
Get alerted when payer policies referencing H0009 are released or updated.
Monitor payer policy activity
Billing Code Overview
HCPCS Level II code H0009 describes alcohol and/or drug services; acute detoxification (hospital inpatient). The service represents medically managed detoxification for patients experiencing acute withdrawal from alcohol or other substances. The typical service type is acute detoxification, and the usual site of service is hospital inpatient settings.
National Reimbursement Benchmarks
Commercial rates for HCPCS H0009 vary notably across national payers with BUCA serving as an average-commercial reference at $240.9. Blue Cross Blue Shield shows the highest central tendency with a median of $335.3 and a wide interquartile spread, while Aetna and Cigna present lower medians near $25.9 and $44.8 respectively. UnitedHealth Group clusters tightly around a median of $45.5, and Cigna sits close by, indicating a cluster of payers in the lower mid-range relative to BUCA.
Measuring dispersion by the IQR (P75 minus P25) highlights differences in rate volatility: Blue Cross Blue Shield has the widest IQR at $275.4 (P75 $513.8 minus P25 $324.0), indicating substantial variability among its allowed amounts. Aetna’s IQR is $229.2 (P75 $254.2 minus P25 $25.0), also large, while UnitedHealth Group is the tightest with an IQR of $22.8 (P75 $55.3 minus P25 $32.5), followed by Cigna with an IQR of $22.4 (P75 $54.4 minus P25 $32.0).